Elos Medtech expands production capacity in Tianjin, China

Elos Medtech signed an agreement amendment with a global healthcare customer to provide an additional CNY 90 million in annual production output by end of 2025. The company will invest approximately CNY 50 million in production equipment over two years at its Tianjin site.

“The expansion is a significant step in our plan for growth and strengthens our long-term profitability.”inderes.se

• 1 source
• inderes.seElos Medtech AB: Elos Medtech signs agreement with global healthcare company to expand production capacity - InderesOct 6, 2025

Summarized from public sources; check the original articles before acting on it.